Study on clinical significance of molecular biological abnormality in gastrointestinal malignant lymphoma

Study on clinical significance of molecular biological abnormality in gastrointestinal malignant lymphoma - Study on clinical significance of molecular biological abnormality in gastrointestinal malignant lymphoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027752

Enrollment

540

Registered

2017-06-15

Start date

2017-06-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal malignant lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Prospective study (1) Patients diagnosed with gastrointestinal malignant lymphoma at Kyushu University Hospital. (2) Patients who fully understand this research plan and are able to consent by the principal and the substitute (3) Patients who are aged 20 years or older at the time of acquisition Retrospective study (1) Patients diagnosed with gastrointestinal malignant lymphoma at Kyushu University Hospital from January 1, 1970 to March 31, 2017.

Exclusion criteria

Exclusion criteria: Patients who reject this research In prospective study, fresh frozen specimens are not collected if the patient has bleeding tendency.

Design outcomes

Primary

Measure	Time frame
Correlation between molecular abnormality and prognosis in gastrointestinal malignant lymphoma	—

Secondary

Measure	Time frame
Correlations among clinicopathological features, molecular abnormalities, treatment and prognosis in gastrointestinal malignant lymphoma	—

Countries

Japan

Contacts

Public ContactYuichirou Yoshida

Kyushu University Department of Medicine and Clinical Science, Graduate School of Medical Sciences

yshdychr@med.kyushu-u.ac.jp+81(0)92-642-5261

Outcome results